Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
Clinical trial NCT05964790 · UNKNOWN
Trial details
- NCT number
- NCT05964790
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-30
- Primary completion
- 2024-06-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.